Sana Biotechnology
SANA
SANA
164 hedge funds and large institutions have $258M invested in Sana Biotechnology in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 58 increasing their positions, 33 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.93% more ownership
Funds ownership: 68.86% → 70.78% (+1.9%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
59% less capital invested
Capital invested by funds: $638M → $258M (-$379M)
Holders
164
Holding in Top 10
2
Calls
$3.54M
Puts
$1.57M
Top Buyers
| 1 | +$3.07M | |
| 2 | +$1.67M | |
| 3 | +$1.19M | |
| 4 |
Millennium Management
New York
|
+$1.1M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$780K |
Top Sellers
| 1 | -$3.97M | |
| 2 | -$1.56M | |
| 3 | -$634K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$607K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$552K |